Healthcare Executive Passes Out During Weight Loss Drug Announcement
Gordon Findlay, the Healthcare Executive of Novo Nordisk, fainted Thursday in the Oval Office during an event about weight loss drugs.
Incident Details
The announcement focused on GLP-1 weight loss medications was interrupted when Findlay passed out. President Donald Trump and Dr. Mehmet Oz immediately attended to him.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," said White House Press Secretary Karoline Leavitt. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Event Context
The announcement revealed a deal allowing some obesity drugs from Eli Lilly and Novo Nordisk to be sold in the U.S. for about $150 per month. Multiple speakers took part, including Eli Lilly CEO David Ricks. During Ricks’ speech, Findlay fainted, prompting the press to be evacuated.
White House Deputy Press Secretary Kush Desai reported that Dr. Kennedy left the room to get medical help. The press conference resumed by 1:29 p.m.
Summary
The timely response by White House medical staff ensured Gordon Findlay received prompt care, allowing the event to continue with minimal delay.
Would you like the summary to be more formal or conversational?